We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.
Over 80 case studies, presentations, panel debates & roundtable discussions focused on the key issues in protein & antibody engineering, bispecifics discovery, biotherapeutics development and bioanalysis, as well as the latest insights into production & manufacturing.
27 April 2020 鈥� Day One (Kick-Off Sessions)
Protein Engineering, Expression, Design & Selection
Bioanalysis: Characterisation, Stability Testing And Formulation Development
Biotherapeutics: Discovery & Development 鈥� Oncology & Immuno-Oncology
28 April 2020 鈥� Day Two
Antibody Engineering, Screening, Design, Development
ADC Engineering, Bioconjugates and Fusion Proteins
Biotherapeutics: Discovery & Development 鈥� Oncology & Immuno-Oncology
29 April 2020 鈥� Day Three
Antibody Engineering, Development & Generation (Part 1) and Biotherapeutics: Discovery & Development鈥揘on-Oncology Indications (Part 2)
Bioanalysis: PKPD & Manufacturing
Biotherapeutics: Discovery & Development 鈥� Non-Oncology Indications
PLUS:
Roundtable & Panel Discussions
Pre-Event Webinars
Useful links
Speakers
Tristan VaughanVice President R&D, AstraZeneca, United Kingdom
Venue
Novotel London West
Hammersmith International Ctre, Novotel London West, 1 Shortlands, Hammersmith, London, W6 8DR, United Kingdom
Useful links
Organised by
Contact information
Danielle Dalby
Oxford Global
Godstow Court, Minns Business Park, Botley, Oxford, OX2 0JB
+44 1865 248455
Contact us by email
